Cart
sales@molnova.com
Casein kinase 1δ-IN-6
CAS No. 1579991-01-7
Casein kinase 1δ-IN-6( —— )
Catalog No. M36916 CAS No. 1579991-01-7
Casein kinase 1δ-IN-6 is a potent and selective inhibitor of the protein kinase CK-1δ with an IC50 of 23 nM, demonstrating neuroprotective and anti-inflammatory activity in both in vitro and in vivo assays. Casein kinase 1δ-IN-6 can be used to study neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 177 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 424 | In Stock |
|
| 25MG | 739 | In Stock |
|
| 50MG | 1014 | In Stock |
|
| 100MG | 1423 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2762 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCasein kinase 1δ-IN-6
-
NoteResearch use only, not for human use.
-
Brief DescriptionCasein kinase 1δ-IN-6 is a potent and selective inhibitor of the protein kinase CK-1δ with an IC50 of 23 nM, demonstrating neuroprotective and anti-inflammatory activity in both in vitro and in vivo assays. Casein kinase 1δ-IN-6 can be used to study neurodegenerative diseases.
-
DescriptionCasein kinase 1δ-IN-6 is a potent and selective protein kinase CK-1δ inhibitor with an IC50 of 23 nM. Casein kinase 1δ-IN-6 shows neuroprotective and anti-inflammatory properties both in vitro and in vivo. Casein kinase 1δ-IN-6 is a promising drug candidate and can be used for neurodegenerative diseases research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetCasein Kinase
-
RecptorCasein Kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1579991-01-7
-
Formula Weight370.78
-
Molecular FormulaC16H10ClF3N2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(CC1=CC(Cl)=CC=C1)=O)C=2SC=3C(N2)=CC=C(C(F)(F)F)C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. José A Morales-Garcia, et al. Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson's Disease. ACS Omega. 2017 Aug 31;2(8):5215-5220.?
molnova catalog
related products
-
NMS-P715
NMS-P715 is a highly selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).
-
CK1-IN-1
CK1-IN-1 compound 1c reported in patent WO2015119579A1 is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM 16 nM 73 nM for CK1δ and CK1ε p38σ MAPK respectively.
-
CX-4945 sodium salt
A potent, selective, orally bioavailable, ATP-competitive inhibitor of protein kinase CK2 with Ki of 0.38 nM, CK2α IC50 of 1 nM.
